Phase 1/1b study of PRGN-3005 autologous UltraCAR-T cells manufactured overnight for infusion next day to advanced stage platinum resistant ovarian cancer patients. J. Clin. Oncol. 2023, 41, 5590. [Google Scholar] [CrossRef] Castelletti, L.; Yeo, D.; van Zandwijk, N.; Rasko, J.E...